These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients. Abdelgalil AA, Monir R, Elmetwally M, Ghattas MH, Bazeed FB, Mesbah NM, Abo-Elmatty DM, Mehanna ET. Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242 [Abstract] [Full Text] [Related]
6. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome. Lakkireddy S, Aula S, Kapley A, Swamy AV, Digumarti RR, Kutala VK, Jamil K. Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544 [Abstract] [Full Text] [Related]
12. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease. Li L, Pan Y, Dai L, Liu B, Zhang D. Med Sci Monit; 2016 Jan 04; 22():31-40. PubMed ID: 26726843 [Abstract] [Full Text] [Related]
14. HDAC9 Polymorphisms Predict Susceptibility, Severity, and Short-Term Outcome of Large Artery Atherosclerotic Stroke in Chinese Population. Wang M, Gu M, Li Z, Sun B, Cheng X, Dai Z, Li S, Xiao L, Zhao M, Wang Z, Lin Y, Liu Y, Xu J, Zhang Z, Liu X. J Mol Neurosci; 2019 Jan 04; 67(1):165-171. PubMed ID: 30565168 [Abstract] [Full Text] [Related]
15. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. JAMA Ophthalmol; 2014 May 04; 132(5):521-7. PubMed ID: 24652518 [Abstract] [Full Text] [Related]
16. Prognostic Significance of Plasma VEGFA and VEGFR2 in Acute Ischemic Stroke-a Prospective Cohort Study. Hu Y, Huang S, Shen T, Wang R, Geng M, Wang Y, Zheng Y, Luo Y, Li S. Mol Neurobiol; 2024 Sep 04; 61(9):6341-6353. PubMed ID: 38300447 [Abstract] [Full Text] [Related]
17. Implication of VEGFR2 in systemic lupus erythematosus: a combined genetic and structural biological approach. Vazgiourakis VM, Zervou MI, Eliopoulos E, Sharma S, Sidiropoulos P, Franek BS, Myrthianou E, Melissourgaki M, Niewold TB, Boumpas DT, Goulielmos GN. Clin Exp Rheumatol; 2013 Sep 04; 31(1):97-102. PubMed ID: 23111153 [Abstract] [Full Text] [Related]
18. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively. Okamoto M, Watanabe M, Inoue N, Ogawa K, Hidaka Y, Iwatani Y. Endocr J; 2020 May 28; 67(5):545-559. PubMed ID: 32074519 [Abstract] [Full Text] [Related]
19. Two Novel SNPs in the PLCL2 Gene Associated with Large Artery Atherosclerotic Stroke Identified by Fine-Mapping. Huang X, Zhu Z, Chen Y, Li J, Xia N, Chen S, Geng W, Ye Z. J Mol Neurosci; 2020 Apr 28; 70(4):496-503. PubMed ID: 31970634 [Abstract] [Full Text] [Related]
20. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells. Willis CD, Poluzzi C, Mongiat M, Iozzo RV. FEBS J; 2013 May 28; 280(10):2271-84. PubMed ID: 23374253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]